Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients.
Saved in:
| Title: | Immune checkpoint inhibitor-induced diabetes can potentially be effectively treated with infliximab: a case report of two patients. |
|---|---|
| Authors: | Savion Gaiger N; Medical Oncology, Yale School of Medicine, New Haven, CT, United States., Hurwitz ME; Medical Oncology, Yale School of Medicine, New Haven, CT, United States., Hafez N; Hematology Oncology, Cedars Sinai, Los Angeles, CA, United States., Kluger HM; Medical Oncology, Yale School of Medicine, New Haven, CT, United States., Herold KC; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.; Department of Immunobiology, Yale School of Medicine, New Haven, CT, United States., Perdigoto AL; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.; Department of Internal Medicine, Veterans Administration Hospital, West Haven, CT, United States. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Nov 07; Vol. 16, pp. 1697724. Date of Electronic Publication: 2025 Nov 07 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2025.1697724 |
